))
In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are ...
…
continue reading
Each week, Valentin Fuster, MD, PhD, MACC, records free podcasts highlighting journal findings. To keep clinicians updated on the most important science emerging in clinical and translational cardiology, Dr. Fuster provides an overview of the weekly edition from the Journal of the American College of Cardiology (JACC), as well as a short summary of each manuscript. Encompassing JACC and nine cardiovascular specialty journals, the JACC family of journals rank among the top cardiovascular peer ...
…
continue reading
This occasional series from the American College of Cardiology, developed by members for members, features conversational expert interviews on non-clinical competencies, skills, well-being, and best practices for the entire heart care team.
…
continue reading
The CardioOhio podcast brings you fascinating interviews with local cardiovascular experts, with the goal of providing practical insights on timely topics in cardiology. It is a production of the Ohio Chapter of the American College of Cardiology. Our mission is to serve as the professional home for cardiovascular team members and to optimize cardiovascular health in Ohio.
…
continue reading
1
Systolic Blood Pressure and Pulse Pressure in Heart Failure: Pooled Participant-Level Analysis of Four Trials
8:13
8:13
Play later
Play later
Lists
Like
Liked
8:13
JACC Associate Editor Theresa McDonagh, MBBCH speaks with author Akshay S. Desai, MD, FACC about this paper on pulse pressure published in JACC and presented at AHA. In a pooled analysis of 16,950 patients with chronic HFmrEF or HFpEF enrolled from 4 global randomized clinical trials, a J-shaped relationship was observed between SBP and the risk of…
…
continue reading
1
JACC - SUMMIT 2024: A Video Interview with Harlan Krumholz and Milton Packer| JACC | AHA 2024
49:31
49:31
Play later
Play later
Lists
Like
Liked
49:31
Join Dr. Harlan Krumholz and Dr. Milton Packer as they discuss the groundbreaking SUMMIT trial, a study poised to redefine treatment for heart failure with preserved ejection fraction (HFpEF) linked to obesity. Dive into the trial's unique methodology, compelling results, and transformative implications for patient care.…
…
continue reading
1
JACC - Recap of AHA From Harlan Krumholz, Editor-in-Chief
14:48
14:48
Play later
Play later
Lists
Like
Liked
14:48
Harlan Krumholz, editor-in-chief of JACC, provides a wrap-up of the JACC papers at the AHA Scientific Sessions in Chicago in 2024. JACC's Obesity Revolution page features various trials to provide perspectives on obesity, including SUMMIT, LookAHEAD, and SELECT. Other studies featured include the DANGER trial; REALIZE-K; AMPLATZER; HELIOS-B; a stud…
…
continue reading
1
JACC - Sodium Zirconium Cyclosilicate for Management of Hyperkalemia During Spironolactone Optimization in Patients with Heart Failure
18:09
18:09
Play later
Play later
Lists
Like
Liked
18:09
JACC Associate Editor Michelle M. Kittleson, MD, PhD, FACC, interviews author Mikhail Kosiborod, MD, FACC about his REALIZE-K study published in JACC and presented at AHA. In participants with HFrEF and hyperkalemia, SZC led to large improvements in the percentage of participants with normokalemia while on optimal spironolactone dose, and reduced r…
…
continue reading
1
JACC - Semaglutide Improves Cardiovascular Outcomes in Patients With History of Coronary Artery Bypass Graft and Obesity
17:23
17:23
Play later
Play later
Lists
Like
Liked
17:23
JACC Associate Editor Marc P. Bonaca, MD, FACC, speaks with author Subodh Verma, MD, PhD, and A. Michael A. Lincoff, MD, FACC, about this brief report published in JACC and presented at AHA. Following CABG surgery there remains a markedly high risk of persistent ischemic events, heart failure, and mortality. Semaglutide consistently reduced all car…
…
continue reading
1
JACC - Tirzepatide Reduces LV Mass and Paracardiac Adipose Tissue in Obesity-Related Heart Failure: SUMMIT CMR Substudy
14:01
14:01
Play later
Play later
Lists
Like
Liked
14:01
JACC Associate Editor Neha J. Pagidipati, MD, FACC, speaks with author Christopher M. Kramer, MD, FACC about this substudy of the SUMMIT trial published in JACC and presented at AHA, demonstrating that tirzepatide therapy in obesity-related HFpEF led to reduced LV mass and paracardiac adipose tissue as compared to placebo and the change in LV mass …
…
continue reading
1
JACC - Outpatient Worsening Heart Failure in Patients with ATTR CM in the HELIOS-B Trial | JACC | AHA 2024
10:57
10:57
Play later
Play later
Lists
Like
Liked
10:57
JACC: Associate Editor Michelle M. Kittleson, MD, PhD, FACC, talks with authors Scott Solomon, MD, FACC and. Marianna Fontana, MD, about their study published in JACC and presented at AHA. Outpatient worsening heart failure (HF) (oral diuretic intensification or initiation) is simple to assess and has been shown to be prognostic of mortality in pat…
…
continue reading
1
JACC - Five-Year Results from the AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial
10:47
10:47
Play later
Play later
Lists
Like
Liked
10:47
JACC Deputy Editor Erica S. Spatz, MD, FACC, joins author Rishi Wadhera, MD, to discuss his paper on rural and urban differences in cardiovascular mortality in the United States, and the impact of the COVID-19 pandemic.
…
continue reading
1
JACC - Intensive lifestyle intervention, cardiac biomarkers, and cardiovascular outcomes in diabetes: LookAHEAD cardiac biomarker ancillary study
6:17
6:17
Play later
Play later
Lists
Like
Liked
6:17
JACC Associate Editor Muthiah Vaduganathan, MD speaks with author Ambarish Pandey, MD about the LookAHEAD trial published in JACC and presented at AHA. Among adults with T2D and overweight/obesity in the Look Action for Health in Diabetes (AHEAD) trial, an intensive lifestyle intervention targeting weight loss led to sustained reductions in hs-cTnT…
…
continue reading
1
JACC - DanGer Shock trial: The impact of age | JACC | AHA 2024
14:23
14:23
Play later
Play later
Lists
Like
Liked
14:23
JACC: Associate Editor Celina Yong, MD, interviews author Jacob Eifer Møller, PhD about his DANGER SHOCK paper presented at AHA and published in JACC. The DanGer Shock trial demonstrated reduced mortality in patients with STEMI-related cardiogenic shock treated with a microaxial flow pump (mAFP). This secondary analysis assessed whether age affecte…
…
continue reading
1
JACC - Oxidized Phospholipids and Calcific Aortic Valvular Disease
16:41
16:41
Play later
Play later
Lists
Like
Liked
16:41
JACC Associate Editor Marc P. Bonaca, MD, FACC, has a discussion with author Sotirios Tsimikas, MD, FACC about this study on phospholipids presented at AHA and published in JACC. In MESA, both OxPL-apoB and Lp(a) were independently associated with prevalent AVC with a significant interaction between the two (p less than 0.01). OxPL-apoB and Lp(a) w…
…
continue reading
1
JACC - Accelerometer-Measured Sedentary Behavior & Risk of Future Cardiovascular Disease | JACC | AHA 2024
8:00
8:00
Play later
Play later
Lists
Like
Liked
8:00
JACC Associate Editor Xiaoxi Yao, MPH, MS, PhD, FACC, interviews author Shaan Khurshid, MD and Ezimamaka Ajufo, MD, about their study on sedentary behavior presented at AHA and published in JACC. Beyond serving as a marker for insufficient physical activity, sedentary behavior may directly affect risk of future cardiovascular (CV) disease. In 89,53…
…
continue reading
1
JACC - P2Y12 Inhibitor Pretreatment in Non-ST Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry
15:45
15:45
Play later
Play later
Lists
Like
Liked
15:45
JACC Associate Editor Seng Chan You, MD, and author Hiroki Ueyama, MD discuss this study presented at AHA and published in JACC. NCDR study finds a steady decline in P2Y12 inhibitor pretreatment for NSTE-ACS in the US, but significant variability persists among operators, institutions, and regions. This practice was not associated with any benefits…
…
continue reading
1
JACC - Hospital-Cardiologist Integration and Outcomes | JACC | AHA 2024
16:09
16:09
Play later
Play later
Lists
Like
Liked
16:09
JACC Associate Editor Jason H. Wasfy, MD, MPhil, FACC interviews author Vinay Kini, MD, FACC about this hospital integration study published in JACC and presented at AHA. Cardiologist employment by hospitals is increasing, but the impact on care quality is not well understood. The study identified cardiologists who cared for acute myocardial infarc…
…
continue reading
1
JACC - Rural-Urban Differences in Cardiovascular Mortality in the United States, 2010-2022
13:43
13:43
Play later
Play later
Lists
Like
Liked
13:43
JACC Deputy Editor Erica S. Spatz, MD, FACC, joins author Rishi Wadhera, MD, to discuss his paper on rural and urban differences in cardiovascular mortality in the United States, and the impact of the COVID-19 pandemic.
…
continue reading
1
JACC: Case Reports - TEER for SAM of the Mitral Valve and Flail Posterior Mitral Leaflet: One Clip Solution
9:33
9:33
Play later
Play later
Lists
Like
Liked
9:33
JACC: Case Reports Associate Editor Maurizio Taramasso, MD, PhD, joins author Brinder S Kanda, MD, FACC to discuss their case presented at AHA and published in JACC: Case Reports. In this case, an 83-year-old female with decompensated heart failure was found to have HOCM with SAM of the mitral valve and a large P2 flail segment with ruptured cords.…
…
continue reading
1
Traditional Chinese Medicine in Cardiovascular Disease: Bridging a Cultural Divide
17:09
17:09
Play later
Play later
Lists
Like
Liked
17:09
What is the current state of evidence behind the use of traditional Chinese medicine in the treatment of cardiovascular disease? Dr. Iokfai Cheang sheds light on this topic through both a clinical and research lens as we discuss the Luobing theory of traditional Chinese medicine.
…
continue reading
Dr. Danyan Xu is a chief physician, professor, and the director of the Cardiac Rehabilitation Unit of the Department of Cardiovascular Medicine of the Second Xiangya Hospital, Central South University. She shares insights into cardiac rehabilitation. Moderated by Dr. Zhangling Chen.
…
continue reading
